{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:56:32Z","timestamp":1792698992350,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011313.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000}}],"reference-count":93,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011313.pub3","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T20:42:42Z","timestamp":1579898562000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma"],"prefix":"10.1002","author":[{"given":"Omar","family":"Abdel-Rahman","sequence":"first","affiliation":[{"name":"University of Alberta and Cross Cancer Institute; Department of Oncology; Edmonton Alberta Canada T6G 1Z2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Elsayed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ain Shams University; Clinical Oncology; Cairo Egypt 11661"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"issue":"19","key":"10.1002\/14651858.CD011313.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","article-title":"SIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma","volume":"36","author":"Chow","year":"2018","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Kolligs F Bilbao J Jakobs T I\u00f1arrairaegui M Nagel J Rodriguez M Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma Liver International 2015 1715 21","DOI":"10.1111\/liv.12750"},{"issue":"2","key":"10.1002\/14651858.CD011313.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00270-014-1012-0","article-title":"Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma","volume":"38","author":"Pitton","year":"2015","journal-title":"Cardiovascular and Interventional Radiology"},{"issue":"6","key":"10.1002\/14651858.CD011313.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jhep.2019.08.006","article-title":"Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma","volume":"71","author":"Ricke","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD011313.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/liv.12637","article-title":"In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?","volume":"35","author":"Fouly","year":"2015","journal-title":"Liver International"},{"issue":"2","key":"10.1002\/14651858.CD011313.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jhep.2014.03.023","article-title":"Prospective randomized pilot study of Y90 +\/- sorafenib as bridge to transplantation in hepatocellular carcinoma","volume":"61","author":"Kulik","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD011313.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0010|cit10","unstructured":"Transarterial radioembolisation versus chemoembolisation for the treatment of HCC: a multicenter randomised controlled trial (TRACE trial) Ongoing study September 2011"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0011|cit11","unstructured":"A phase III clinical trial of intra-arterial theraSphere\u00ae in the treatment of patients with unresectable hepatocellular carcinoma Ongoing study"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/s10620-0132872-x","article-title":"Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature","volume":"58","author":"Abdel-Rahman","year":"2013","journal-title":"Digestive Disease and Science"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"4763832","DOI":"10.1155\/2018\/4763832","article-title":"The expanding role of systemic therapy in the management of hepatocellular carcinoma","volume":"2018","author":"Abdel-Rahman","year":"2018","journal-title":"Canadian Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines 3: rating the quality of evidence - introduction","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"28","key":"10.1002\/14651858.CD011313.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.3748\/wjg.14.4445","article-title":"Hepatocellular carcinoma: defining the place of surgery in an era of organ shortage","volume":"14","author":"Bartlett","year":"2008","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive - trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD011313.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13643-018-0770-1","article-title":"Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis","volume":"7","author":"Castellini","year":"2018","journal-title":"Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011313.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4143\/crt.2005.37.5.290","article-title":"Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma","volume":"37","author":"Choi","year":"2005","journal-title":"Cancer Research and Treatment"},{"issue":"96","key":"10.1002\/14651858.CD011313.pub3-BIB0021|cit21","first-page":"1683","article-title":"A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma","volume":"56","author":"D'Avola","year":"2009","journal-title":"Hepato-gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD011313.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods of combining randomised clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011313.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","author":"EASL","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for the Study of the Liver","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD011313.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"European Journal of Cancer"},{"issue":"18","key":"10.1002\/14651858.CD011313.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4254\/wjh.v8.i18.770","article-title":"Transarterial radioembolization vs chemoembolization for hepatocarcinoma patients: a systematic review and meta-analysis","volume":"8","author":"Facciorusso","year":"2016","journal-title":"World Journal of Hepatology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0029|cit29","unstructured":"FACT-Hep: For patients with Hepatobiliary cancer (liver, bile duct and pancreas) www.facit.org\/FACITOrg\/Questionnaires"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jclinepi.2018.10.009","article-title":"Increased risks for random errors are common in outcomes graded as high certainty of evidence","volume":"106","author":"Gartlehner","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0031|cit31","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.transproceed.2012.07.151","article-title":"Transplantation for hepatocellular carcinoma in younger patients has an equivocal survival advantage as compared with resection","volume":"45","author":"Graham","year":"2013","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines: 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011313.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011313.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing Summary of Findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD011313.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jclinepi.2012.08.001","article-title":"GRADE guidelines: 13. Preparing Summary of Findings tables - continuous outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD011313.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 15. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jclinepi.2017.05.005","article-title":"GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence","volume":"87","author":"Guyatt","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0046|cit46","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 6 (updated July 2019). The Cochrane Collaboration, 2019 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0048|cit48","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"120","key":"10.1002\/14651858.CD011313.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"11","key":"10.1002\/14651858.CD011313.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomised trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jso.20609","article-title":"Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: down staging to resection, RFA and bridge to transplantation","volume":"94","author":"Kulik","year":"2006","journal-title":"Journal of Surgical Oncology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.alcohol.2012.03.006","article-title":"Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study","volume":"46","author":"Kwon","year":"2012","journal-title":"Alcohol (Fayetteville, N.Y.)"},{"issue":"6","key":"10.1002\/14651858.CD011313.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gut.50.6.881","article-title":"Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto","volume":"50","author":"Levy","year":"2002","journal-title":"Gut"},{"issue":"8","key":"10.1002\/14651858.CD011313.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial down staging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"American Journal of Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD011313.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"e103228","DOI":"10.1371\/journal.pone.0103228","article-title":"Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou Criteria Staging Systems","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/sim.698","article-title":"A comparison of methods to detect publication bias in meta-analysis","volume":"20","author":"Macaskill","year":"2001","journal-title":"Statistics in Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011313.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MNM.0b013e3283619d24","article-title":"The PERCIST criteria: an insightful appraisal","volume":"34","author":"Maffione","year":"2013","journal-title":"Nuclear Medicine Communications"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub3-BIB0058|cit58","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"2","author":"Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-60327-376-3_8","article-title":"Hepatitis C and hepatocellular carcinoma","volume-title":"Hepatocellular Carcinoma Diagnosis and Treatment","author":"Masuzaki","year":"2009"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0061|cit61","unstructured":"Patel A Hepatocellular Carcinoma Staging https:\/\/emedicine.medscape.com\/article\/2007061-overview"},{"issue":"9128","key":"10.1002\/14651858.CD011313.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/978-1-60327-522-4_20","article-title":"Yttrium-90 radioembolotherapy for hepatocellular cancer","volume-title":"Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary Care","author":"Murthy","year":"2011"},{"issue":"7","key":"10.1002\/14651858.CD011313.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"736-42; quiz 74","DOI":"10.1016\/j.jclinepi.2013.02.004","article-title":"The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses","volume":"66","author":"Mustafa","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD011313.pub3-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004787.pub2","article-title":"Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma","author":"Oliveri","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"24","key":"10.1002\/14651858.CD011313.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0068|cit68","unstructured":"The Nordic Cochrane Centre, Cochrane Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.RVI.0000177063.92678.21","article-title":"The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma","volume":"16","author":"Rhee","year":"2005","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jhep.2010.10.004","article-title":"Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation","volume":"54","author":"Riaz","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD011313.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomised controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jcm8010055","article-title":"History and evolution of yttrium-90 radioembolization for hepatocellular carcinoma","volume":"8","author":"Saini","year":"2019","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD011313.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncologist"},{"issue":"35","key":"10.1002\/14651858.CD011313.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD011313.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011313.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: the ROBES Meta-Epidemiologic Study","volume":"187","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD011313.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4149\/av_2012_03_235","article-title":"Hepatitis C virus and other risk factors in hepatocellular carcinoma","volume":"56","author":"Schiefelbein","year":"2012","journal-title":"Acta Virologica"},{"issue":"5","key":"10.1002\/14651858.CD011313.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study","volume":"187(5)","author":"Savovi\u0107","year":"2018","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0082|cit82","first-page":"57","article-title":"Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals","volume":"2","author":"Thorlund","year":"2010","journal-title":"Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0083|cit83","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0084|cit84","unstructured":"Copenhagen Trial Unit TSA - Trial Sequential Analysis 2011"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.crad.2017.07.021","article-title":"Radioembolisation of hepatocellular carcinoma: a primer","volume":"72","author":"Venkatanarasimha","year":"2017","journal-title":"Clinical Radiology"},{"issue":"12","key":"10.1002\/14651858.CD011313.pub3-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003046.pub3","article-title":"Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma","author":"Weis","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in a random-effects meta-analysis","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD011313.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD011313.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"42","key":"10.1002\/14651858.CD011313.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.3748\/wjg.14.6437","article-title":"Evolution of systemic therapy of advanced hepatocellular carcinoma","volume":"14","author":"Yau","year":"2008","journal-title":"World Journal of Gastroenterology"},{"issue":"9","key":"10.1002\/14651858.CD011313.pub3-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011313","article-title":"Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma","author":"Abdel-Rahman","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011313.pub3-BIB0093|cit93","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011313.pub2","article-title":"Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma","author":"Abdel-Rahman","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011313.pub4","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"record-id":"25814"},{"DOI":"10.1002\/14651858.cd011313.pub4","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011313.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:54:48Z","timestamp":1628549688000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011313.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":93,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011313.pub3","relation":{"withdrawal":[{"id-type":"doi","id":"10.1002\/14651858.CD011313.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]}}}